10XB-101 Injections for Excess Side Fat
Trial Summary
What is the purpose of this trial?
This trial tests a special injection to reduce fat on both sides of the lower back. It targets people with excess fat in this area. The injection works by breaking down and removing the fat.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are taking medications that affect clotting or platelet function.
What data supports the effectiveness of the drug 10XB-101 for reducing excess side fat?
How does the drug 10XB-101 differ from other treatments for excess side fat?
Research Team
John Dobak, M.D.
Principal Investigator
10xBio, LLC
Eligibility Criteria
This trial is for adults aged 18-55 with stable body weight who have excess fat on both sides of their waist (bilateral flank adiposity). They must be willing to receive monthly injections, follow the study's instructions, and attend all visits over a year. Pregnant individuals or those with clotting issues, loose skin in the target area, or allergies to ingredients in the injection cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive injections of the study drug or placebo every 4 weeks for up to 6 treatments
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- 10XB-101 Solution for Injection
- Placebo Solution for Injection (no active ingredient)
Find a Clinic Near You
Who Is Running the Clinical Trial?
10xBio, LLC
Lead Sponsor
Therapeutics, Inc.
Industry Sponsor